Intravenous immunoglobulins in the third millennium

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Boca Raton [u.a.] Parthenon Publ. Group 2004
Ausgabe:1. publ.
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zc 4500
001 BV017828191
003 DE-604
005 20061127
007 t|
008 040203s2004 xxud||| |||| 00||| eng d
010 |a 2004040032 
020 |a 1842142585  |9 1-84214-258-5 
035 |a (OCoLC)54029446 
035 |a (DE-599)BVBBV017828191 
040 |a DE-604  |b ger  |e aacr 
041 0 |a eng 
044 |a xxu  |c US 
049 |a DE-19  |a DE-29 
050 0 |a RM282.I44 
082 0 |a 615/.37  |2 22 
245 1 0 |a Intravenous immunoglobulins in the third millennium  |c ed. by Marinos C. Dalakas ... 
250 |a 1. publ. 
264 1 |a Boca Raton [u.a.]  |b Parthenon Publ. Group  |c 2004 
300 |a XX, 420 S.  |b graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
500 |a Includes bibliographical references and index 
650 4 |a Immunoglobulins  |x Therapeutic use 
650 4 |a Immunoglobulins, Intravenous  |x therapeutic use 
650 0 7 |a Immunglobuline  |0 (DE-588)4026626-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Intravenöse Applikation  |0 (DE-588)4525889-2  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Immunglobuline  |0 (DE-588)4026626-6  |D s 
689 0 1 |a Intravenöse Applikation  |0 (DE-588)4525889-2  |D s 
689 0 |5 DE-604 
700 1 |a Dalakas, Marinos C.  |e Sonstige  |4 oth 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-010701545 

Datensatz im Suchindex

DE-BY-UBM_katkey 2976039
DE-BY-UBM_media_number 99994086706
_version_ 1823052792257839104
adam_text Contents List of speakers and chairpersons xi Foreword xix Two decades of experience with intravenous immunoglobulin 1 1. Manufacturing of intravenous immunoglobulin: challenges, 3 achievements and opportunities A. Morell 2. Challenges and achievements in pathogen safety of intravenous immunoglobulin 9 P.J. Spdth and C. Kempf 3. Treatment modalities and clinical efficacy of immunoglobulin G replacement 21 therapies in primary immunodeficiency A. D. B. Webster 4. Immunomodulation by intravenous immunoglobulin: idiopathic 29 thrombocytopenic purpura as a model P. Imbach 5. Witnessing the introduction and use of intravenous immunoglobulin in neurology 37 M. C. Dalakas 6. Pharmacoeconomics of intravenous immunoglobulin administration in 41 neurological disorders: the US experience P. D. Donofrio V 7. Pharmacoeconomics of intravenous immunoglobulin for polyneuropathies 47 P. McCrone Intravenous immunoglobulin in immunodeficiencies and severe 51 infections molecular aspects and clinical use 8. B cell maturation to produce high affinity antibodies of different isotypes 53 and its abnormalities A. Durandy 9 The molecular basis of primary immune deficiency diseases 57 H. D. Ochs, T. R. Torgerson, W. I. Lee, Y. Z.Jin, E. Gambineri and Q. Zhu 10. Safety in intravenous immunoglobulin therapy 71 E. W. Gelfand 11. Immunoglobulin replacement by the subcutaneous route using preparations 77 licensed in the USA for administration by other routes M. Berger, K. DuffJ. Poll and S. Roy 12. The use of intravenous immunoglobulin for allogeneic stem cell transplantation: 81 the US experience R. H. Buckley 13. Intravenous immunoglobulin for bone marrow/stem cell transplantation: 85 the European experience K. Theunissen, J. A. Maertens and M. A. Boogaerts 14. Secondary antibody deficiency following treatment of vasculitis: 91 the use of intravenous immunoglobulin V.J Tormey and A. Burns 15. Intravenous immunoglobulin in the prevention and treatment of severe infections 95 K. Werdan Immunomodulatory and anti inflammatory potential of 103 intravenous immunoglobulin 16. Mechanisms of action of intravenous immunoglobulin in autoimmune 105 and inflammatory diseases M. D. Kazatchkine, J. Bayry, S. Lacroix Desmazes and S. V Kaveri 17. Role of intravenous immunoglobulin in reversing glucocorticoid 113 insensitivity or resistance E. W. Gelfand 18. Modulating the balance of activating and inhibiting Fey receptors: 121 mechanism of intravenous immunoglobulin action L. Pricop 19 Anti inflammatory effects of intravenous immunoglobulin: Fey receptor 127 inhibition/blockade and non Fey receptor mediated mechanisms J. W. Semple and A. H. Lazarus 20. Immune modulation by intravenous immunoglobulin: some remarks on 133 the role of Fc receptors E. van Mirre and C. E. Hack 21. Intravenous immunoglobulin in reactive hemophagocytic syndrome: 137 a paradigm of Fey receptor and cytokine modulation L. Mouthon 22. Anti inflammatory effects of intravenous immunoglobulin through 143 modulation of complement activities H. U. Lutz and P.J. Spath 23. Changes in gene expression profile in the muscles of patients with 149 dermatomyositis and inclusion body myositis after therapy with intravenous immunoglobulin: a microarray analysis correlating gene expression with clinical outcome R. Raju and M. C. Dalakas 24. In vitro studies of mechanisms of action of intravenous immunoglobulin 153 in Guillain—Barre syndrome and Miller—Fisher syndrome: a review R. Gold, A. Weishaupt, M. Stangel, A. Chan and K. V. Toyka Intravenous immunoglobulin for autoimmune diseases of the 159 peripheral nervous system 25. The immunological rationale for intravenous immunoglobulin in Guillain Barre 161 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy J. D. Pollard 26. Intravenous immunoglobulin for Guillain—Barre syndrome and chronic 171 inflammatory demyelinating polyradiculoneuropathy in adult patients P. A. van Doom 27. Clinical experience with intravenous immunoglobulin for treatment of pediatric 181 Guillain Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy A.J. Kornberg 28. Intravenous immunoglobulin for multifocal motor neuropathy 187 L. H. van den Berg 29. Intravenous immunoglobulins in paraproteinemic demyelinating neuropathies 191 J. M. Leger 30. Immunoglobulins in IgM antimyelin associated glycoprotein and other 197 paraproteinemic neuropathies G. Comi 31. Intravenous immunoglobulin for myasthenia gravis 203 P. Gajdos 32. Intravenous immunoglobulin in polymyositis and dermatomyositis 207 P. Cherin 33. Controlled studies with high dose intravenous immunoglobulin in the 213 treatment of inclusion body myositis M. C. Dalakas Intravenous immunoglobulin for autoimmune diseases of the 219 central nervous system 34. Immune mechanisms and treatment perspectives in multiple sclerosis 221 R. Hohlfeld 35. A review of controlled clinical trials of intravenous immunoglobulin in 229 multiple sclerosis P. S. Sorensen 36. Intravenous immunoglobulin treatment for patients with primary or secondary 235 progressive multiple sclerosis D. Pdhlau and U. Kallweit 37. What is the effective dose of intravenous immunoglobulin for treatment 243 of relapsing—remitting multiple sclerosis? M. Lewanska, M. Siger Zajdel and K. Selmaj 38. High dose intravenous immunoglobulin in the treatment of patients with stiff 257 person syndrome: a controlled study M. C. Dalakas 39. Intravenous immunoglobulin in acute disseminated encephalomyelitis 267 E. Marchioni, S. Ravaglia, A. Todeschini, A. Pichiecchio, C. Vggetti, G. Piccolo and M. Ceroni The use of intravenous immunoglobulin in dermatology 277 40. Intravenous immunoglobulin in dermatology 279 S.Jolles 41. The use of intravenous immunoglobulin therapy in the treatment of 283 autoimmune mucocutaneous blistering diseases A. R. Ahmed 42. Treatment of atopic dermatitis, urticaria and psoriasis with 291 intravenous immunoglobulin M. Rustin 43. Intravenous immunoglobulin in toxic epidermal necrolysis and 297 Stevens—Johnson syndrome L. E. French AA. Intravenous immunoglobulin in the treatment of vasculitis 301 D. Jayne Emerging applications for intravenous immunoglobulin 311 45. Immunomodulation by intravenous immunoglobulin of alloantibodies to 313 human leukocyte antigen: clinical aspects in solid organ transplantation D. Glotz, C. Antoine, P.Julia, B. Pegaz Fiornet, A. Duboust, S. Boudjeltia, R. Fraoui, M. Combes and]. Bariety A6. Role of intravenous immunoglobulin in the management of heart failure 321 H. Krum Al. Intravenous immunoglobulin: potential role in the management of 331 severe acute respiratory syndrome H. H. Chng, K. P. Leong, B. Leung, B. Ang, Y S. Leo, S. Loo, S. K. Goh, T.W.K. Lew, L. Y. Hsu, E. Ami and D. Tai 48. Enhancement of the immune response to Mycobacterium tuberculosis by 337 high dose intravenous immunoglobulin in mice S. Jolles, E. Roy, V. Stavropoulos, S. Coade, E. Grigorieva, R. Tascon and D. Lowrie Potential applications for intravenous immunoglobulin 341 49. Intravenous immunoglobulin for treatment of recurrent miscarriage 343 L. A. E. Noens 50. Epilepsy and the immune system: is there a link? 349 L. G. Lagae 51. Intravenous immunoglobulin as an immunomodulatory agent in 357 systemic lupus erythematosus and lupus nephritis Y. Sherer and Y. Sboenfeld 52. Intravenous immunoglobulin for fibrosis, atherosclerosis and malignant conditions 361 /. Krause and Y. Shoenfeld Summaries of poster sessions 367 53. Intravenous immunoglobulin for immune deficiencies and passive immunization 369 /. Quinti, M. Cagliuso and F. Aiuti 54. The use of intravenous immunoglobulin in hematology and transplantation 373 D. Provan 55. The use of intravenous immunoglobulin in neurology 377 W. K. Engel 56. The use of intravenous immunoglobulin for dermatological disorders 383 M. Sticherling 57. The use of intravenous immunoglobulin in collagen vascular and heart diseases 389 A. H. Lazarus 58. Intravenous immunoglobulin: mechanisms of action 393 P. E. Williams 59 Pathogen safety and tolerability of intravenous immunoglobulin 399 E Rossi 60. Pharmacoeconomics and evidence based medicine 405 G. Antonini and A. Di Pasquale Index 409
any_adam_object 1
building Verbundindex
bvnumber BV017828191
callnumber-first R - Medicine
callnumber-label RM282
callnumber-raw RM282.I44
callnumber-search RM282.I44
callnumber-sort RM 3282 I44
callnumber-subject RM - Therapeutics and Pharmacology
ctrlnum (OCoLC)54029446
(DE-599)BVBBV017828191
dewey-full 615/.37
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
dewey-raw 615/.37
dewey-search 615/.37
dewey-sort 3615 237
dewey-tens 610 - Medicine and health
discipline Medizin
edition 1. publ.
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01652nam a2200433zc 4500</leader><controlfield tag="001">BV017828191</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20061127 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">040203s2004 xxud||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004040032</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1842142585</subfield><subfield code="9">1-84214-258-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)54029446</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV017828191</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM282.I44</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.37</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravenous immunoglobulins in the third millennium</subfield><subfield code="c">ed. by Marinos C. Dalakas ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton [u.a.]</subfield><subfield code="b">Parthenon Publ. Group</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 420 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins, Intravenous</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dalakas, Marinos C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=010701545&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010701545</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV017828191
illustrated Illustrated
indexdate 2025-02-03T16:57:40Z
institution BVB
isbn 1842142585
language English
lccn 2004040032
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-010701545
oclc_num 54029446
open_access_boolean
owner DE-19
DE-BY-UBM
DE-29
owner_facet DE-19
DE-BY-UBM
DE-29
physical XX, 420 S. graph. Darst.
publishDate 2004
publishDateSearch 2004
publishDateSort 2004
publisher Parthenon Publ. Group
record_format marc
spellingShingle Intravenous immunoglobulins in the third millennium
Immunoglobulins Therapeutic use
Immunoglobulins, Intravenous therapeutic use
Immunglobuline (DE-588)4026626-6 gnd
Intravenöse Applikation (DE-588)4525889-2 gnd
subject_GND (DE-588)4026626-6
(DE-588)4525889-2
(DE-588)4143413-4
title Intravenous immunoglobulins in the third millennium
title_auth Intravenous immunoglobulins in the third millennium
title_exact_search Intravenous immunoglobulins in the third millennium
title_full Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ...
title_fullStr Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ...
title_full_unstemmed Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ...
title_short Intravenous immunoglobulins in the third millennium
title_sort intravenous immunoglobulins in the third millennium
topic Immunoglobulins Therapeutic use
Immunoglobulins, Intravenous therapeutic use
Immunglobuline (DE-588)4026626-6 gnd
Intravenöse Applikation (DE-588)4525889-2 gnd
topic_facet Immunoglobulins Therapeutic use
Immunoglobulins, Intravenous therapeutic use
Immunglobuline
Intravenöse Applikation
Aufsatzsammlung
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv AT dalakasmarinosc intravenousimmunoglobulinsinthethirdmillennium